You searched for Antibody candidate - Page 7 of 69

Morphosys Janssen Guselkumab approval psoriasis

News and Trends 18 Sep 2017

Update: After 25 years, MorphoSys Gets its First Antibody Approved

…psoriasis, bringing the first antibody developed by MorphoSys to the market. After celebrating its 25th anniversary last week, MorphoSys is welcoming the approval of the first antibody developed using its…

September 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Nov 2016

This Technology could Open Up a new 4th Generation of Therapeutic Antibodies

…of all therapeutic antibody generations (those with the antibody icon are available at BIOTEM) So how are optimal 4th-gen antibodies developed? 1. Low immunogenicity A foreign antibody can induce an…

November 1, 2016 - 5 minutesmins - By External Contributor

News and Trends 23 Nov 2022

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

…a new antibody therapy that is about to be approved in the U.S. highlights the importance of developing new antibody therapies against Covid-19. “The ever-increasing development of antibody resistance of…

November 23, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 21 Jul 2016

‘Winner Antibody’ holds promise as universal Influenza A Vaccine

…multiple mechanisms to stop infection. The promising candidate is MEDI8852, an antibody initially developed by Humabs (Switzerland). It targets Influenza A virus (the group of viruses known as avian flu),…

July 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 22 Mar 2017

What’s the Gold Standard for Therapeutic Antibodies?

…counts with billions of naturally human antibodies within its universal antibody libraries. Within six weeks, Yumab can sort through billions of candidates to obtain between 10 and 1000 hits with…

March 22, 2017 - 4 minutesmins - By External Contributor

David Chiswell interview Kymab Antibodies

Interview 18 Sep 2017

David Chiswell: “We are getting close to the best way of making antibodies”

…Chiswell was, along with Greg Winter, one of the co-founders of Cambridge Antibody Technology. “We both wanted to start an antibody company,” says Chiswell. “And if you have an opportunity…

September 18, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…cell engager. The clinical candidate DR-0201 is an antibody that targets and engages specific myeloid cells – immune cells that originate in the bone marrow – to induce deep B-cell…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 22 Jun 2023

Alchemab Therapeutics unveils Alzheimer’s candidate

Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium…

June 22, 2023 - 3 minutesmins - By Jim Cornall

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

…Less than a month after Lilly’s announcement, Biogen released positive data on its Phase 1b trial of aducanumab, an antibody candidate now in Phase III trials, reviving hopes for the…

January 31, 2017 - 7 minutesmins - By Diana Kwon

Best in Biotech 16 Jan 2025

Ten first-in-class drugs on track for FDA approval in 2025

…two main components: Monoclonal antibody (telisotuzumab): This antibody specifically binds to the c-Met protein on the surface of cancer cells. Cytotoxic agent (monomethyl auristatin E – MMAE): Once the antibody…

January 16, 2025 - 13 minutesmins - By Jules Adam

Numab Ono Pharmaceutical Immuno Oncology

News and Trends 28 Mar 2017

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

…sales, in exchange for the development of an immuno-oncology antibody candidate. For Numab, this deal with an oncology veteran certainly reinforces the potential of its antibody technology. The Japanese company…

March 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Ulrich dauer vivoryon alzheimers disease

Interview 23 Nov 2022

What recent mixed clinical results can teach about Alzheimer’s disease

…Abeta. Varoglutamstat also blocks the pathology earlier in the process than leading antibody candidates, and can be taken orally — a more convenient drug delivery than injecting or infusing antibody…

November 23, 2022 - 7 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Update: After 25 years, MorphoSys Gets its First Antibody Approved

This Technology could Open Up a new 4th Generation of Therapeutic Antibodies

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

‘Winner Antibody’ holds promise as universal Influenza A Vaccine

What’s the Gold Standard for Therapeutic Antibodies?

David Chiswell: “We are getting close to the best way of making antibodies”

Top biotech deals of March 2025

Alchemab Therapeutics unveils Alzheimer’s candidate

Biologicals on the Brain: Biotech in Neurodegenerative Disease

Ten first-in-class drugs on track for FDA approval in 2025

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

What recent mixed clinical results can teach about Alzheimer’s disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!